معرفی
Dr. Jason Cai is an Associate Professor at Yale University, with primary appointments in the Yale School of Medicine under Radiology & Biomedical Imaging and a secondary appointment in Pharmacology. His expertise spans Medicinal Chemistry, Radiopharmaceutical Sciences, and Neurodegenerative Diseases.
- Education: PhD in Chemistry from the University of Missouri-Columbia (2011), followed by a postdoctoral fellowship in radiopharmaceutical development at the University of Pittsburgh.
- Research Focus: Development of PET imaging probes for synaptic density, drug pharmacokinetics, and neurodegenerative disorders like Alzheimer’s and essential tremor, as well as oncology applications.
His recent publications highlight innovations in PET imaging for synaptic loss quantification, PARP1-targeted theranostics, and first-in-human trials of SV2A tracers. He has received prestigious awards including the NIH K01, SNMMI Berson-Yalow Award, and Archer Foundation Research Scholar Award. Dr. Cai’s work bridges Pharmacology, Molecular Imaging, and Neurooncology, with affiliations to institutions like the Mental Health PET Radioligand Development Program and Yale Cancer Center.
